Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV‐associated oropharyngeal cancer.

MLA

Zarrabi, Kevin K., et al. “Assessing Plasma Circulating Tumor Human Papillomavirus (HPV) DNA in Determining Treatment Response in HPV‐associated Oropharyngeal Cancer.” Head & Neck, vol. 44, no. 8, Aug. 2022, pp. E25–30. EBSCOhost, https://doi.org/10.1002/hed.27081.

APA

Zarrabi, K. K., Galloway, T. J., Flieder, D. B., Kumar, S. S., Judd, J., & Bauman, J. R. (2022). Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV‐associated oropharyngeal cancer. Head & Neck, 44(8), E25–E30. https://doi.org/10.1002/hed.27081

Chicago

Zarrabi, Kevin K., Thomas J. Galloway, Douglas B. Flieder, Sameera S. Kumar, Julia Judd, and Jessica R. Bauman. 2022. “Assessing Plasma Circulating Tumor Human Papillomavirus (HPV) DNA in Determining Treatment Response in HPV‐associated Oropharyngeal Cancer.” Head & Neck 44 (8): E25–30. doi:10.1002/hed.27081.